94709-12-3

Usage

Uses

Used in Pharmaceutical Industry:
(3,5-DIMETHOXYPHENYL)(4-METHOXYPHENYL)-METHANONE is used as a bioavailability enhancer for certain drugs, improving the absorption and effectiveness of these medications within the body.
Used in Nutraceutical Industry:
(3,5-DIMETHOXYPHENYL)(4-METHOXYPHENYL)-METHANONE is used as a supplement for its potential anti-inflammatory and antioxidant properties, contributing to overall health and well-being.
Used in Traditional Medicine:
(3,5-DIMETHOXYPHENYL)(4-METHOXYPHENYL)-METHANONE is used in traditional medicine practices for its long-standing reputation as a remedy for various ailments, leveraging its historical use and therapeutic potential.
Used in Culinary Industry:
(3,5-DIMETHOXYPHENYL)(4-METHOXYPHENYL)-METHANONE is used as a seasoning in various cuisines, adding a distinctive pungent flavor to dishes and enhancing the overall taste experience.

InChI:InChI=1/C16H16O4/c1-18-13-6-4-11(5-7-13)16(17)12-8-14(19-2)10-15(9-12)20-3/h4-10H,1-3H3

Upstream product

• 100-66-3 methoxybenzene 
• 17213-57-9 3,5-dimethoxybenzoyl chloride 
• 75-15-0 carbon disulfide 
• 7446-70-0 aluminium trichloride 
• 365564-07-4 3,5-dimethoxyphenylboronic acid pinacol ester 
• 151-10-0 1,3-Dimethoxybenzene 
• 201230-82-2 carbon monoxide 
• 696-62-8 para-iodoanisole 
• 192182-54-0 3,5-dimethoxyphenylboronic acid 
• 93993-82-9 4,6-Dimethoxy-2-<4-methoxy-benzyl>-benzoyl-ameisensaeure 
• 1132-21-4 3,5-dimethoxybenzoic acid 
• 104-92-7 1-bromo-4-methoxy-benzene 
• 95281-06-4 3,5,4'-Trimethoxy-benzophenon-carbonsaeure-⁽²⁾ 

Relevant academic research and scientific papers

Highly Selective and Divergent Acyl and Aryl Cross-Couplings of Amides via Ir-Catalyzed C-H Borylation/N-C(O) Activation

Herein, we demonstrate that amides can be readily coupled with nonactivated arenes via sequential Ir-catalyzed C-H borylation/N-C(O) activation. This methodology provides facile access to biaryl ketones and biaryls by the sterically controlled Ir-catalyzed C-H borylation and divergent acyl and decarbonylative amide N-C(O) and C-C activation. The methodology diverts the traditional acylation and arylation regioselectivity, allowing us to directly utilize readily available arenes and amides to produce valuable ketone and biaryl motifs.

Carbonylative Suzuki-Miyaura coupling catalyzed by palladium supported on aminopropyl polymethylsiloxane microspheres under atmospheric pressure of CO

Carbonylative Suzuki-Miyaura cross-coupling reactions of various aryl iodides with phenylboronic acids were catalyzed by palladium supported on amino-modified silica microspheres. Reactions performed with a very low concentration of Pd, under the atmospheric pressure of CO, led to high/moderate yields of multiple benzophenones.

Palladium nanoparticles supported on a nickel pyrazolate metal organic framework as a catalyst for Suzuki and carbonylative Suzuki couplings

Methanolic reduction of [PdCl2(CH3CN)2] on a [Ni(2,5-di(1H-pyrazol-4-yl)benzenesulfonate)2] metal organic framework gives rise to Pd2+/Pd0 nanocomposites with Suzuki and carbonylative Suzuki heterogeneous catalytic activities.

Antineoplastic agents. 465. Structural modification of resveratrol: Sodium resverastatin phosphate

As an extension of structure/activity investigations of resveratrol (1), phenstatin (2c), and the cancer antiangiogenesis drug sodium combretastatin A-4 phosphate (2b), syntheses of certain related stilbenes (14) and benzophenones (16) were undertaken. The trimethyl ether derivative of (Z)-resveratrol (4a) exhibited the strongest activity (GI50 = 0.01-0.001 μg/mL) against a minipanel of human cancer cell lines. A monodemethylated derivative (14c) was converted to prodrug 14n (sodium resverastatin phosphate) for further biological evaluation. The antitubulin and antimicrobial activities of selected compounds were also evaluated.